Similar articles

• Why the European Parliament rejected the patenting of human genes.

  Grace M. Grace M. Gene Ther. 1995 Oct;2(8):509-11. Gene Ther. 1995. PMID: 8593600 No abstract available.
• The gene patenting controversy: a convergence of law, economic interests, and ethics.

  Kevles DJ, Berkowitz A. Kevles DJ, et al. Brooklyn Law Rev. 2001 Fall;67(1):233-48. Brooklyn Law Rev. 2001. PMID: 12645549 No abstract available.
• Is it right or is it useful? Patenting of the human gene, Lockean property rights, and the erosion of the imago Dei.

  Cunningham PC. Cunningham PC. Ethics Med. 2003 Summer;19(2):85-98. Ethics Med. 2003. PMID: 15025114 No abstract available.
• Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.

  Schrell A, Bauser H, Brunner H. Schrell A, et al. Adv Biochem Eng Biotechnol. 2007;107:13-39. doi: 10.1007/10_2007_049. Adv Biochem Eng Biotechnol. 2007. PMID: 17522818 Review.
• Biotechnology--a challenge to the patent system.

  Farnley S, Morey-Nase P, Sternfeld D. Farnley S, et al. Curr Opin Biotechnol. 2004 Jun;15(3):254-7. doi: 10.1016/j.copbio.2004.04.004. Curr Opin Biotechnol. 2004. PMID: 15193336 Review.